Sequencing Technologies

Kalorama’s World Market for Clinical Sequencing and Sequencing-Based IVD Products, 2026 analyzes clinical sequencing instruments, consumables, software, and diagnostic products, with forecasts through 2030.

SDi’s Market Landscape: Sequencing report analyzes the sequencing market’s sizing, five-year forecasts, vendor shares, and the litigation and regulatory trends shaping Illumina, Oxford Nanopore, PacBio, and emerging entrants.

Kalorama’s 105-page clinical proteomics report sizes the market by technology and region through 2030, covering mass spectrometry, high-plex affinity assays, digital immunoassays, and spatial proteomics, with company profiles of 16 vendors and analysis of deals, approvals, and trends from 2021 to 2026.

Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023…

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

Kalorama Information presents the latest insights and comprehensive analysis in its new report, The Market for RNA Sequencing, 3rd Edition. This essential market research report delves into the rapidly evolving RNA sequencing sector, highlighting the remarkable advancements and applications that promise to revolutionize healthcare.

 

Overview:

In the past decade, the sequencing market has witnessed…

Single cell RNA-seq enables new types of analyses, for instance: understanding tumour heterogeneity and clonal evolution (including studying lineage analysis, cancer stem cells, and drug-resistant and metastatic clones), understanding complex tissues (e.g. neural tissues), high resolution identification of cell types and markers, and understanding differentiation pathways in developmental and systems biology.

Explore the dynamic market…

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of…

Single Cell Analysis in Next-Generation Sequencing Markets (NGS): Market Size and Forecast, Segment Breakouts, Secondary Research, 2022-2027 delves into the rapidly growing market for single cell genomics products, including hardware, software, consumables, and services associated with sequencing and downstream analysis.

 

Report Highlights:

• Market Overview:
  • Detailed analysis of the single cell genomics market,…

Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS), 2021 provides a detailed market summary, covering NGS sample preparation revenues and growth rates for 2021-2026.

The report presents the following market data:

• Library Preparation and Target Enrichment Market Size
• Library Preparation and Target Enrichment, Growth to 2026
• Library Preparation and Target Enrichment, Products on…

Molecular diagnostics is a rapidly evolving and dynamic field, representing the fastest-growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine, influencing various aspects of healthcare such as early identification of antimicrobial resistant (AMR) infections, companion diagnostics for cancer treatment, pharmacokinetics for HIV, psychiatric conditions, and blood…

The genetic involvement in the pathogenesis of neurological diseases is profound, with central nervous system disorders accounting for about 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, represent the final frontier in medical discovery. Advances in testing, such as next-generation sequencing (NGS), have been instrumental in…